Lv12
40 积分 2025-08-27 加入
Pemigatinib for Myeloid/Lymphoid Neoplasms with FGFR1 Rearrangement
27分钟前
待确认
Antitumor Activity of the Selective MDM2 Antagonist Nutlin-3 Against Chemoresistant Neuroblastoma With Wild-Type p53
5天前
已完结
In VitroCharacterization of a Potent p53-MDM2 Inhibitor, RG7112 in Neuroblastoma Cancer Cell Lines
5天前
已完结
Inhibition of MDM2 by RG7388 confers hypersensitivity to X‐radiation in xenograft models of childhood sarcoma
6天前
已完结
Lisaftoclax in Combination with Alrizomadlin Overcomes Venetoclax Resistance in Acute Myeloid Leukemia and Acute Lymphoblastic Leukemia: Preclinical Studies
7天前
已完结
MDM2 and DNMT1 inhibitors induce neuroblastoma cell death through p53-dependent and independent pathways
11天前
已完结
Expression of Thy 1.2 surface antigen increases significantly during the murine mesenchymal stem cells cultivation period
11天前
已完结
Advancements in neuroblastoma treatment: FDA-approved drugs and role of phytochemicals
11天前
已完结
Neuroblastoma: An Updated Review on Biology and Treatment
11天前
已完结
MDM2 inhibitors in sarcomas: results and next steps
14天前
已完结
皖公网安备34019202002308
